News

A study by Nagoya University Graduate School of Medicine in Japan suggests the importance of tailored exercise programs for ...
This story was originally reported by Barbara Rodriguez of The 19th. In mid-March, the parents of a 6-year-old girl in Texas ...
The Children’s Health Defense has inserted itself into the outbreak with a media operation that repeatedly disputes the MMR ...
Six people have contracted Legionnaires' disease after spending time in Sydney's CBD over the past three weeks. People who have been in the CBD over the past 10 days are advised to remain alert ...
Vaccines remain a cornerstone of prevention, but low vaccination rates, waning immunity in older adults, or the absence of available vaccines — as is the case with HSV — highlight the need for new ...
In view of the growing incidence of non-communicable diseases (NCDs) such as cancer and diabetes, Apollo Hospitals Enterprise Ltd will invest ₹6,000 crore over five years to add 3,500 beds ...
What's more, "strep" – which also causes a bizarre flesh-eating disease – had become shockingly resistant to common antibiotics. Group A streptococcus (GAS) – which may be best known by one ...
Treatment for mitochondrial diseases within reach Date: April 9, 2025 Source: University of Gothenburg Summary: A medical breakthrough could result in the first treatment for rare but serious ...
Dr. Omar Al-Heeti is an assistant professor of medicine at Southern Illinois University and practices internal medicine with a specialty in infectious diseases. He received his medical degree from ...
One of the great successes of public health in the US is the newborn screening program, which tests infants in every state for more than 30 serious but treatable congenital diseases. For the four ...
In Singapore, “I see about five to 10 patients a year; some in my patients with Parkinson’s disease,” she said. Then, Dr Neo mentioned something that set off all kinds of alarm in my head: ...
Merida has developed a novel platform to precisely target the pathogenic antibodies that underpin a wide array of autoimmune and allergic diseases. Merida is developing antibody-like therapeutics ...